Champions Oncology, Inc. (CSBR) vs InterCure Ltd. (INCR)
A side-by-side comparison of Champions Oncology, Inc. and InterCure Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CSBR
Champions Oncology, Inc.
$5.02HealthcareDelayed quote: Oct 6, 2026, 1:49 PM EDT
INCR
InterCure Ltd.
$5.39HealthcareDelayed quote: Oct 6, 2026, 1:45 PM EDT
Total return — CSBR vs INCR
growth of $100 · dividends reinvested · last 8yCSBR -49.8% (-8.3%/yr)INCR -68.0% (-13.3%/yr)CSBR compounded faster over this window
CSBR INCR
CSBR vs INCR: by the numbers
- •CSBR is the larger company ($70M vs $64M market cap).
- •Both run net losses; CSBR's is the smaller (-1.87% vs -13.72% net margin).
- •INCR grew revenue faster over the past five years (32.71% vs 7.25% CAGR).
Metrics side by side
Valuation
| Metric | CSBR | INCR |
|---|---|---|
| Forward P/E | 50.20 | N/A |
| P/S ratio | 1.15 | 0.80 |
| P/B ratio | 17.92 | 0.51 |
| EV / EBITDA | 262.40 | N/A |
| FCF yield | N/A | 11.52% |
Profitability
| Metric | CSBR | INCR |
|---|---|---|
| Gross margin | 49.30% | 14.40% |
| Operating margin | -1.72% | 2.49% |
| Net margin | -1.87% | -13.72% |
| ROE | -29.15% | -8.80% |
| ROIC | -6.75% | -4.72% |
Growth (annualized)
| Metric | CSBR | INCR |
|---|---|---|
| Revenue CAGR (5Y) | 7.25% | 32.71% |
| Total return CAGR (5Y) | -13.07% | -30.85% |
Frequently asked
- Which has grown faster, CSBR or INCR?
- Over the past five years, INCR grew revenue faster — CSBR at a 7.25% CAGR versus INCR at 32.71%.
- How have CSBR and INCR total returns compared?
- Over the past 5 years, CSBR delivered -13.07% and INCR delivered -30.85% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Champions Oncology ROEInterCure ROEChampions Oncology operating marginInterCure operating marginChampions Oncology revenue growthInterCure revenue growthChampions Oncology free cash flowInterCure free cash flow
Champions Oncology & InterCure appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.